These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 26318099)

  • 1. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).
    Rickli A; Luethi D; Reinisch J; Buchy D; Hoener MC; Liechti ME
    Neuropharmacology; 2015 Dec; 99():546-53. PubMed ID: 26318099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs).
    Luethi D; Trachsel D; Hoener MC; Liechti ME
    Neuropharmacology; 2018 May; 134(Pt A):141-148. PubMed ID: 28720478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT
    Eshleman AJ; Wolfrum KM; Reed JF; Kim SO; Johnson RA; Janowsky A
    Biochem Pharmacol; 2018 Dec; 158():27-34. PubMed ID: 30261175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.
    Eshleman AJ; Forster MJ; Wolfrum KM; Johnson RA; Janowsky A; Gatch MB
    Psychopharmacology (Berl); 2014 Mar; 231(5):875-88. PubMed ID: 24142203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.
    Elmore JS; Decker AM; Sulima A; Rice KC; Partilla JS; Blough BE; Baumann MH
    Neuropharmacology; 2018 Nov; 142():240-250. PubMed ID: 29501528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines.
    Kolaczynska KE; Luethi D; Trachsel D; Hoener MC; Liechti ME
    Front Pharmacol; 2019; 10():1423. PubMed ID: 31849671
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives).
    Luethi D; Widmer R; Trachsel D; Hoener MC; Liechti ME
    Eur J Pharmacol; 2019 Jul; 855():103-111. PubMed ID: 31063768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
    Fantegrossi WE; Harrington AW; Eckler JR; Arshad S; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
    Psychopharmacology (Berl); 2005 Sep; 181(3):496-503. PubMed ID: 15983786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines.
    Kolaczynska KE; Luethi D; Trachsel D; Hoener MC; Liechti ME
    Front Pharmacol; 2021; 12():794254. PubMed ID: 35222010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
    Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review.
    Kamińska K; Świt P; Malek K
    J Anal Toxicol; 2021 Jan; 44(9):947-956. PubMed ID: 32128596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT
    Åstrand A; Guerrieri D; Vikingsson S; Kronstrand R; Green H
    Forensic Sci Int; 2020 Dec; 317():110553. PubMed ID: 33160102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission.
    Herian M; Wojtas A; Sobocińska MK; Skawski M; González-Marín A; Gołembiowska K
    Pharmacol Rep; 2020 Dec; 72(6):1593-1603. PubMed ID: 33174181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1.
    Simmler LD; Buchy D; Chaboz S; Hoener MC; Liechti ME
    J Pharmacol Exp Ther; 2016 Apr; 357(1):134-44. PubMed ID: 26791601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of
    Tirri M; Bilel S; Arfè R; Corli G; Marchetti B; Bernardi T; Boccuto F; Serpelloni G; Botrè F; De-Giorgio F; Golembiowska K; Marti M
    Front Psychiatry; 2022; 13():875722. PubMed ID: 35530025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.
    Halberstadt AL
    Curr Top Behav Neurosci; 2017; 32():283-311. PubMed ID: 28097528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of novel psychoactive benzofurans.
    Rickli A; Kopf S; Hoener MC; Liechti ME
    Br J Pharmacol; 2015 Jul; 172(13):3412-25. PubMed ID: 25765500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.